JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Total Liabilities
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has total liabilities worth $25.69 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check JIN MEDICAL INTERNATIONAL LTD. Ordinary (ZJYL) asset resilience to evaluate the company's liquid asset resilience ratio.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Total Liabilities Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see JIN MEDICAL INTERNATIONAL LTD. Ordinary (ZJYL) total assets.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cegedim S.A.
PA:CGM
|
France | €704.39 Million |
|
Igarashi Motors India Limited
NSE:IGARASHI
|
India | Rs3.68 Billion |
|
Fu Chun Shin Machinery Manufacture Co Ltd
TWO:6603
|
Taiwan | NT$5.75 Billion |
|
Molecular Partners AG
SW:MOLN
|
Switzerland | CHF16.62 Million |
|
KHVATEC Co.Ltd
KQ:060720
|
Korea | ₩172.59 Billion |
|
LVMC Holdings
KO:900140
|
Korea | ₩196.53 Billion |
|
Tavia Acquisition Corp. Unit
NASDAQ:TAVIU
|
USA | $1.41 Million |
|
Invesco Trust For Inv Grade NY Munis
NYSE:VTN
|
USA | $78.55 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is JIN MEDICAL INTERNATIONAL LTD. Ordinary 's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual total liabilities of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $23.80 Million | +37.96% |
| 2024-09-30 | $17.25 Million | +93.27% |
| 2023-09-30 | $8.92 Million | +56.46% |
| 2022-09-30 | $5.70 Million | -27.54% |
| 2021-09-30 | $7.87 Million | -21.38% |
| 2020-09-30 | $10.01 Million | +3.69% |
| 2019-09-30 | $9.66 Million | -0.22% |
| 2018-09-30 | $9.68 Million | -- |
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more